Price target upside
Evommune Price Target: +332% vs Current Price
Direct answer
Evommune's analyst target implies +332%.
The average target is $22.33 compared with a recorded current price of $5.17.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked October 19, 2026.
Get free Evommune email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $5.17
- Average price target
- $22.33
- High price target
- $30.00
- Low price target
- $8.00
- Low target gap
- +54.7%
- Target upside
- +332%
- High target gap
- +480.3%
- Target range width
- 425.5%
- Consensus rating
- Buy
- Analysts
- 9
- Evidence date
- October 19, 2026
- Valid through
- October 26, 2026
Explore related company data
Read the frequently asked questions.
How much upside or downside does Evommune's average target imply?
Evommune's average target is $22.33 versus a recorded price of $5.17. The difference is +332%.
How far are Evommune's low and high targets from the recorded price?
The low target implies +54.7%, while the high target implies +480.3%.
How many analysts are included in Evommune's consensus?
The verified consensus includes 9 analysts.
How is Evommune's target upside or downside calculated?
The average target of $22.33 is divided by the recorded price of $5.17, then one is subtracted to produce +332%. This does not guarantee a future return.
When was Evommune's analyst forecast verified?
The data was verified on 2026-10-19. The dataset is valid through 2026-10-26.